RR27 Antibody

What is the RR27 antibody and what is its target protein?

The RR27 antibody is a rabbit polyclonal IgG antibody that specifically recognizes the RR27 protein from Oryza sativa subsp. japonica (Rice) . The antibody is produced using recombinant RR27 protein as the immunogen, which allows for specific binding to the target protein . The target protein, RR27, is identified by the UniProt Number Q75HW2 and functions in rice plant biology . For researchers studying plant immunity or protein expression in rice, this antibody serves as a valuable tool for detecting and quantifying RR27 protein levels. The polyclonal nature of this antibody means it recognizes multiple epitopes on the target protein, potentially offering greater sensitivity compared to monoclonal antibodies, especially when protein conformation may be altered during experimental procedures.

What are the validated applications for RR27 antibody?

Based on manufacturer specifications, the RR27 antibody has been validated for use in Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blotting (WB) applications . In ELISA applications, the antibody can be used to detect and quantify the presence of RR27 protein in plant extracts or purified protein samples. For Western Blotting, the antibody allows for size-based detection of the RR27 protein following separation by SDS-PAGE. When designing experiments with this antibody, researchers should consider that while these are the validated applications, optimization may be required for specific experimental conditions or sample types. Similar to other research antibodies, additional applications such as immunoprecipitation or immunohistochemistry may be possible but would require independent validation by the researcher before implementation in formal studies.

What controls should be included when using RR27 antibody in experiments?

When designing experiments with the RR27 antibody, several controls should be incorporated to ensure valid interpretation of results. The antibody package includes 200μg of recombinant immunogen protein/peptide that serves as a positive control, as well as 1ml of pre-immune serum that can function as a negative control . The positive control confirms the antibody's ability to detect its target under the experimental conditions, while the pre-immune serum helps establish background signals and non-specific binding. Additionally, researchers should consider including:

• A tissue or sample known to lack RR27 expression as a negative biological control

• Samples with verified RR27 expression at different levels to establish a dose-response relationship

• Primary antibody omission controls to check for non-specific binding of secondary detection reagents

• Isotype controls to distinguish between specific binding and Fc-receptor mediated binding in certain applications

These controls strengthen experimental validity and facilitate interpretation of potentially complex or subtle results in plant protein research.

How can epitope mapping enhance the utility of RR27 antibody in plant research?

Epitope mapping of the RR27 antibody can significantly enhance its research applications by providing precise information about antibody-antigen interactions. Similar to studies conducted with other antibodies, epitope mapping techniques such as peptide arrays, site-directed mutagenesis, or hydrogen-deuterium exchange mass spectrometry could identify the specific amino acid sequences recognized by the RR27 antibody . Understanding whether the antibody binds to membrane-distal, external-facing residues (as seen with CD27 antibodies) or other structural elements can predict accessibility of the epitope in different experimental conditions . This knowledge allows researchers to:

• Design better fusion proteins or truncation mutants for functional studies

• Predict potential cross-reactivity with related proteins

• Optimize denaturation conditions in Western blotting to expose or preserve epitopes

• Interpret conflicting results between different detection methods based on epitope availability

For instance, if the epitope contains critical residues like the D420 in SARS-CoV-2 studies, which forms a salt bridge with antibody residues, this could explain binding stability or sensitivity to certain buffer conditions .

What strategies can address cross-reactivity concerns when working with plant antibodies like RR27?

Cross-reactivity is a significant concern when working with plant antibodies due to the high conservation of many plant proteins across species. While the RR27 antibody is developed against rice RR27 protein, researchers should implement several strategies to address potential cross-reactivity:

• Perform extensive validation using both positive controls (recombinant immunogen provided with the antibody) and negative controls (tissues or extracts lacking the target protein)

• Conduct Western blot analysis with samples from multiple plant species to assess cross-species reactivity, particularly important when studying conserved plant proteins

• Consider pre-absorption experiments where the antibody is pre-incubated with purified target protein to confirm signal specificity

• Implement peptide competition assays similar to the p27 competitive antibody assay methodology described for RSV studies, where binding to the target is competed with synthetic peptides representing different regions of the protein

• Include knockout or knockdown plant samples when available to conclusively demonstrate specificity

Addressing cross-reactivity systematically enhances confidence in experimental results and prevents misinterpretation of data in comparative plant studies.

How can RR27 antibody be integrated into multiplexed detection systems for plant proteomics?

Integrating RR27 antibody into multiplexed detection systems enables researchers to simultaneously analyze multiple proteins in plant samples, enhancing experimental efficiency and providing contextual protein expression data. Based on approaches used with other research antibodies, several strategies can be employed:

• Fluorescent multiplexing: Combine RR27 antibody with antibodies against other targets labeled with different fluorophores, ensuring antibodies are raised in different host species to prevent cross-reactivity of secondary antibodies

• Sequential reprobing: Strip and reprobe Western blots with RR27 and other antibodies, carefully documenting complete stripping using appropriate controls

• Bead-based multiplexing: Couple RR27 antibody to distinguishable beads in suspension array systems similar to those used in clinical antibody research, allowing simultaneous detection of multiple targets in a single sample

• Mass cytometry: Label RR27 antibody with isotope tags for mass cytometry applications in plant cell analysis, enabling high-dimensional protein profiling

When implementing these approaches, researchers should conduct validation experiments to ensure that the presence of multiple antibodies does not interfere with RR27 binding specificity or sensitivity. Additionally, careful consideration of isotype compatibility and potential cross-reactivity between detection reagents is essential for accurate data interpretation.

What are the optimal conditions for using RR27 antibody in Western blotting applications?

Optimizing Western blotting conditions for the RR27 antibody requires systematic evaluation of several parameters to achieve maximum specificity and sensitivity. Based on general practices with similar antibodies and the specific characteristics of the RR27 antibody, researchers should consider:

• Sample preparation: For plant tissues, optimize protein extraction buffers to effectively solubilize RR27 while minimizing proteolytic degradation. Consider testing different detergents (CHAPS, Triton X-100, SDS) and protease inhibitor combinations.

• Gel percentage and transfer conditions: Since the molecular weight of the target protein affects migration and transfer efficiency, optimize the acrylamide percentage based on the size of RR27. For proteins with post-translational modifications, consider gradient gels.

• Blocking reagents: Test different blocking agents (BSA, non-fat milk, commercial blockers) to determine which provides the best signal-to-noise ratio with the RR27 antibody. Plant samples often contain compounds that can interfere with certain blockers.

• Antibody dilution: Establish a dilution curve to determine the optimal concentration of the RR27 antibody that maximizes specific signal while minimizing background. Starting with manufacturer recommendations (if provided), test dilutions ranging from 1:500 to 1:5000 .

• Incubation conditions: Compare different incubation temperatures (4°C, room temperature) and durations (1 hour to overnight) to optimize binding while minimizing non-specific interactions.

• Detection method: Evaluate chemiluminescent, fluorescent, and colorimetric detection systems to determine which provides the appropriate sensitivity for your experimental needs.

Systematic optimization of these parameters should be documented to establish a reproducible protocol for detecting RR27 protein in plant samples.

How should researchers optimize ELISA protocols when using the RR27 antibody?

ELISA optimization with the RR27 antibody requires careful consideration of multiple variables to achieve consistent and sensitive detection of the target protein in plant samples. Researchers should consider the following methodology:

• ELISA format selection: Determine whether direct, indirect, sandwich, or competitive ELISA is most appropriate based on sample complexity and research question. For quantitative analysis of RR27 in complex plant extracts, a sandwich ELISA using the RR27 antibody as either the capture or detection antibody may provide optimal specificity.

• Antigen immobilization: When using direct or indirect ELISA, optimize coating buffer composition (carbonate-bicarbonate, phosphate, or Tris) and pH (typically 7.4-9.6) to maximize antigen binding while preserving epitope structure. Test different coating concentrations and incubation times.

• Blocking optimization: Evaluate different blocking agents (BSA, casein, commercial blockers) at various concentrations (1-5%) to minimize background while preserving specific binding.

• Antibody concentration: Perform a checkerboard titration to determine optimal primary antibody concentration, typically starting with dilutions between 1:500 and 1:5000 based on antibody concentration (10mg stock) .

• Sample preparation: Develop extraction protocols that effectively solubilize RR27 while minimizing interfering compounds common in plant tissues. Consider sample clarification methods (centrifugation, filtration) and potential need for sample dilution.

• Detection system: Compare different enzyme-conjugated secondary antibodies and substrates (HRP/TMB, AP/pNPP) to identify the system providing the best sensitivity and dynamic range for your specific application.

• Data analysis: Establish appropriate standard curves using the provided recombinant immunogen protein to enable accurate quantification of RR27 in experimental samples.

Systematic optimization and documentation of these parameters will ensure reproducible and reliable ELISA results with the RR27 antibody.

What approaches can improve reproducibility when working with RR27 antibody across different experiments?

Ensuring reproducibility with the RR27 antibody across different experiments requires implementing robust standardization practices. Researchers should consider the following methodological approaches:

• Antibody aliquoting and storage: Upon receiving the antibody, create multiple small-volume aliquots to minimize freeze-thaw cycles. Store at -20°C or -80°C as recommended by the manufacturer . Document lot numbers and create an internal validation protocol for each new lot.

• Standard operating procedures (SOPs): Develop detailed protocols for all experimental procedures involving the RR27 antibody, including specific buffer compositions, incubation times and temperatures, and equipment settings.

• Reference standards: Utilize the provided recombinant immunogen protein as a consistent positive control across experiments. Consider creating an internal reference sample (e.g., a pooled plant extract with known RR27 expression) that can be included in each experiment.

• Normalization strategies: Implement appropriate normalization approaches, such as:

  • Internal loading controls for Western blots (housekeeping proteins)

  • Reference gene products for relative quantification

  • Spiking samples with known quantities of recombinant protein for recovery assessment

• Statistical quality control: Establish acceptance criteria for experimental results, including:

  • Minimum signal-to-noise ratios

  • Maximum acceptable coefficient of variation between technical replicates

  • Standard curve parameters (R² values, slope ranges)

• Electronic laboratory notebooks: Document all experimental conditions, reagent details, and raw data in a structured format that facilitates comparison across experiments and operators.

• Antibody validation: Periodically revalidate the antibody using orthogonal methods (e.g., mass spectrometry) to confirm continued specificity, similar to approaches used in antibody databases for validation tracking .

Implementing these approaches systematically will enhance experimental reproducibility and facilitate troubleshooting when variations occur.

How can researchers address weak or absent signals when using RR27 antibody?

When confronted with weak or absent signals using the RR27 antibody, researchers should implement a systematic troubleshooting approach that addresses multiple potential failure points in the experimental workflow:

• Antibody functionality verification:

  • Perform a dot blot with the provided recombinant immunogen protein to verify antibody activity

  • Check antibody storage conditions and freeze-thaw history

  • Consider testing an alternative lot or source if available

• Target protein considerations:

  • Verify expression levels of RR27 in your experimental system

  • Assess potential protein degradation during sample preparation by including protease inhibitors

  • Consider that post-translational modifications might mask epitopes

  • Evaluate whether experimental conditions might affect protein expression (stress, developmental stage, tissue-specific expression)

• Technical optimization:

  • Increase antibody concentration or extend incubation time

  • Modify blocking conditions to reduce potential epitope masking

  • For Western blotting, try different membrane types (PVDF vs. nitrocellulose) and transfer methods

  • For ELISA, optimize coating buffer composition and antigen concentration

  • Enhance detection sensitivity by using amplification systems (biotin-streptavidin, tyramide signal amplification)

• Sample preparation refinement:

  • Test alternative extraction buffers that might better preserve protein structure or improve solubilization

  • Consider enrichment approaches to concentrate the target protein prior to analysis

  • Evaluate different sample processing methods to minimize interfering compounds in plant extracts

Each modification should be tested systematically, changing only one variable at a time, to identify the specific factor limiting signal generation.

What strategies can resolve non-specific binding issues with RR27 antibody?

Non-specific binding is a common challenge when working with antibodies, particularly polyclonal antibodies like RR27. Implementing the following methodological strategies can help resolve these issues:

• Blocking optimization:

  • Test different blocking agents (BSA, casein, commercial blockers) at various concentrations

  • Extend blocking time to ensure complete coverage of non-specific binding sites

  • Consider adding low concentrations of detergents (0.05-0.1% Tween-20) to washing and antibody dilution buffers

• Antibody incubation conditions:

  • Dilute antibody in blocking buffer rather than plain buffer

  • Reduce antibody concentration to minimize non-specific interactions

  • Optimize incubation temperature (4°C may reduce non-specific binding compared to room temperature)

  • Include carrier proteins (0.1-1% BSA) in antibody dilution buffer

• Pre-absorption techniques:

  • Use the pre-immune serum provided with the antibody to identify background binding

  • Consider pre-absorbing the antibody with extracts from tissues not expressing the target protein

  • For Western blots, compare patterns with those obtained using the pre-immune serum to identify non-specific bands

• Washing optimization:

  • Increase washing stringency with higher salt concentrations (150-500 mM NaCl)

  • Extend washing duration or increase the number of washing steps

  • Add low concentrations of non-ionic detergents to washing buffers

• Secondary antibody considerations:

  • Test alternative secondary antibodies from different manufacturers

  • Use highly cross-adsorbed secondary antibodies to minimize cross-reactivity

  • Include controls lacking primary antibody to identify non-specific binding of secondary antibodies

Systematic implementation and documentation of these approaches will help establish conditions that maximize specific binding while minimizing non-specific interactions.

How can researchers interpret contradictory results between different detection methods using RR27 antibody?

When faced with contradictory results between different detection methods (e.g., ELISA vs. Western blot) using the RR27 antibody, researchers should consider several methodological factors that might explain the discrepancies:

• Epitope accessibility differences:

  • In Western blotting, proteins are denatured, potentially exposing epitopes that might be hidden in native conditions used in ELISA

  • Conduct epitope mapping studies to determine if the antibody recognizes conformational or linear epitopes, similar to approaches used with other antibodies

  • Test native vs. denatured samples in both methods when possible

• Sensitivity and detection threshold variations:

  • Quantitatively compare detection limits of both methods using dilution series of recombinant protein

  • Consider that amplification systems differ between methods, affecting sensitivity

  • Evaluate whether contradictions occur only near detection limits

• Interference factors specific to each method:

  • For Western blots, assess whether size-based detection might be affected by protein fragmentation or aggregation

  • For ELISA, evaluate whether components in plant extracts might interfere with antibody binding in solution

  • Test purified or semi-purified samples to reduce matrix effects

• Validation using orthogonal methods:

  • Implement a third, independent method (e.g., immunoprecipitation followed by mass spectrometry)

  • Use genetic approaches (e.g., overexpression, knockdown) to manipulate target protein levels and confirm antibody specificity

  • Consider competitive binding assays with the recombinant immunogen to verify signal specificity in both methods

• Cross-reactivity assessment:

  • Determine if the antibody might recognize different proteins or protein modifications in different assay formats

  • Perform immunoprecipitation followed by Western blotting to identify potential cross-reactive proteins

  • Consider that plant samples might contain proteins with similar epitopes that behave differently in various assay formats

By systematically investigating these factors, researchers can resolve contradictions and develop a more comprehensive understanding of both the antibody's performance characteristics and the biological system under study.

How can RR27 antibody be adapted for use in immunohistochemistry or immunofluorescence studies?

Although the RR27 antibody is primarily validated for ELISA and Western blotting applications , researchers interested in visualizing RR27 protein localization in plant tissues could adapt it for immunohistochemistry (IHC) or immunofluorescence (IF) using the following methodological approaches:

• Fixation optimization:

  • Test different fixatives (paraformaldehyde, glutaraldehyde, ethanol-based fixatives) to preserve antigen while maintaining tissue architecture

  • Optimize fixation duration to balance tissue preservation with epitope accessibility

  • Evaluate the need for antigen retrieval methods (heat-induced, enzymatic) to expose epitopes that might be masked during fixation

• Sectioning and preparation considerations:

  • Compare results from paraffin-embedded, frozen, and vibratome sections

  • For plant tissues, optimize cell wall permeabilization protocols to facilitate antibody penetration

  • Consider whole-mount approaches for certain tissues or developmental stages

• Blocking and antibody incubation:

  • Test higher concentrations of blocking agents to overcome plant tissue autofluorescence

  • Evaluate longer antibody incubation times (overnight to several days) to improve penetration

  • Implement extensive washing steps to reduce background

• Detection system selection:

  • For IHC, compare different enzyme-substrate combinations (HRP-DAB, AP-Fast Red)

  • For IF, select fluorophores with emission spectra distinct from plant autofluorescence

  • Consider signal amplification methods (tyramide signal amplification, antibody sandwich approaches)

• Validation strategies:

  • Include tissues known to lack RR27 expression as negative controls

  • Use pre-immune serum on serial sections as a control for non-specific binding

  • When possible, validate localization patterns with tagged RR27 constructs or in situ hybridization

• Counterstaining approaches:

  • Select counterstains compatible with plant tissue (calcofluor white for cell walls, DAPI for nuclei)

  • Optimize counterstaining protocols to provide context without overwhelming the specific signal

By systematically developing and validating these protocols, researchers can extend the utility of the RR27 antibody beyond its current applications to include spatial information about protein expression and localization.

What considerations should guide researchers when using RR27 antibody for protein interaction studies?

When adapting the RR27 antibody for protein interaction studies such as co-immunoprecipitation (co-IP) or proximity ligation assays (PLA), researchers should consider several methodological factors to ensure valid results:

• Antibody orientation and immobilization:

  • Determine whether direct immobilization or indirect capture (using anti-rabbit secondary antibodies) provides better results

  • Test different immobilization supports (protein A/G beads, magnetic beads, activated sepharose) to optimize capacity and minimize non-specific binding

  • Consider site-specific biotinylation approaches for oriented immobilization, similar to techniques used for p27 peptide studies

• Buffer optimization for preserving interactions:

  • Evaluate different lysis and binding buffers to balance solubilization efficiency with preservation of protein-protein interactions

  • Test various detergent types and concentrations (non-ionic vs. ionic, concentration gradients)

  • Optimize salt concentrations to reduce non-specific binding while maintaining specific interactions

• Crosslinking considerations:

  • For transient interactions, evaluate reversible crosslinkers (DSP, DTBP) to stabilize complexes during isolation

  • Optimize crosslinking time and concentration to capture interactions without creating artificial aggregates

  • Include appropriate controls to distinguish between direct and indirect interactions

• Validation strategies:

  • Perform reciprocal co-IPs when possible, using antibodies against suspected interaction partners

  • Include negative controls lacking the target protein or using pre-immune serum

  • Validate key interactions using orthogonal methods (yeast two-hybrid, split-reporter assays)

• Analytical approaches:

  • Consider mass spectrometry analysis of immunoprecipitated complexes to identify novel interaction partners

  • Implement stringent filtering criteria to distinguish true interactors from common contaminants

  • Verify biological relevance through functional studies of identified interactions

• Protocol refinements for plant samples:

  • Address plant-specific challenges such as abundant photosynthetic proteins or secondary metabolites

  • Consider subcellular fractionation prior to immunoprecipitation to enrich for relevant cellular compartments

  • Optimize extraction conditions to handle plant-specific compounds that might interfere with antibody binding

Careful optimization and validation of these parameters will enable researchers to generate reliable data on RR27 protein interactions in plant biology.

What future developments might enhance the utility of RR27 antibody in plant research?

Several technological and methodological advancements could significantly enhance the utility of the RR27 antibody in future plant research:

• Epitope-specific modifications:

  • Development of monoclonal variants with defined epitope specificity, similar to approaches used for other research antibodies

  • Generation of recombinant antibody fragments (scFv, Fab) for improved tissue penetration and reduced background

  • Epitope mapping to enable rational antibody engineering for specific applications

• Technical enhancements:

  • Development of directly conjugated formats (fluorophores, enzymes) to eliminate secondary antibody requirements

  • Creation of bifunctional reagents combining RR27 recognition with proximity labeling capabilities

  • Integration with emerging single-cell technologies for higher resolution analysis of RR27 expression patterns

• Validation expansions:

  • Comprehensive cross-reactivity profiling across plant species to define the evolutionary conservation of recognized epitopes

  • Extended application validation beyond ELISA and Western blotting to include immunohistochemistry, flow cytometry, and super-resolution microscopy

  • Development of standardized reference materials to facilitate inter-laboratory comparisons

• Database integration:

  • Assignment of Resource Research Identifier (RRID) numbers to track use across research studies

  • Inclusion in antibody validation databases with user-contributed data on performance in various applications

  • Development of comprehensive epitope databases linking antibody binding sites to protein structure and function

• Multiplexing capabilities:

  • Creation of panels including RR27 and other plant protein antibodies for simultaneous detection

  • Development of barcoded antibody formats for high-dimensional protein profiling

  • Integration with spatial transcriptomics approaches for correlative protein-RNA analysis

These advancements would transform the RR27 antibody from a basic research tool into a sophisticated reagent for addressing complex questions in plant biology, potentially revealing new insights into RR27 protein function and regulation in rice and related species.

How should researchers evaluate the relevance of RR27 antibody studies to broader plant biology questions?

When considering how RR27 antibody studies relate to broader questions in plant biology, researchers should implement a systematic framework for evaluating relevance and potential impact:

• Evolutionary conservation assessment:

  • Analyze sequence homology of RR27 across plant species to identify conserved domains and potential functional significance

  • Consider whether findings in rice might extend to other cereals or more distant plant families

  • Evaluate whether RR27 belongs to protein families with known functions in plant development, stress response, or other key processes

• Functional context evaluation:

  • Place RR27 within known signaling or metabolic pathways based on protein interaction studies

  • Consider temporal and spatial expression patterns that might indicate developmental or stress-responsive roles

  • Evaluate potential post-translational modifications that could regulate activity under different conditions

• Comparative analysis strategies:

  • Develop approaches to compare RR27 expression or modification across various genotypes, treatments, or environmental conditions

  • Consider systems biology approaches integrating transcriptomic, proteomic, and metabolomic data to place RR27 in broader cellular context

  • Evaluate whether RR27 expression correlates with specific phenotypes of agricultural or ecological significance

• Translational potential assessment:

  • Consider whether insights about RR27 might inform crop improvement strategies

  • Evaluate potential connections to stress tolerance, yield components, or other agronomically relevant traits

  • Develop hypotheses about how manipulation of RR27 might affect plant performance in agricultural settings

• Methodological advancement considerations:

  • Assess whether techniques developed for RR27 study might be applicable to other challenging plant proteins

  • Consider whether the antibody might serve as a model for developing improved immunological tools in plant science

  • Evaluate potential for method standardization to facilitate comparative studies across laboratories